DermaCare
DermaCare, licence 80037495: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Vegecort
- Licence holder
- Himalaya Wellness USA Ltd.
- NPN or DIN-HM
- 80037495
- Status
- Active licence
- Licence date
- 15 November 2012
- Revision date
- 15 November 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Terminalia bellirica Source : Écorce du fruit Extraction ratio : 2.86:1 Dry plant equivalent : 11.44 mg | 4.0 mg | Not calculated |
| Mallotus philippensis Source : Glandular hairs of fruit Extraction ratio : 100:1 Dry plant equivalent : 240.00 mg | 2.4 mg | Not calculated |
| Cyperus rotundus Source : Tubercule Extraction ratio : 9.09:1 Dry plant equivalent : 54.54 mg | 6.0 mg | Not calculated |
| Terminalia chebula Source : Écorce du fruit Extraction ratio : 1.67:1 Dry plant equivalent : 6.68 mg | 4.0 mg | Not calculated |
| Psoralea corylifolia Source : Semence(s) Extraction ratio : 9.09:1 Dry plant equivalent : 21.82 mg | 2.4 mg | Not calculated |
| Commiphora mukul Source : Oleo-gum resin Extraction ratio : 1.89:1 Dry plant equivalent : 6.05 mg | 3.2 mg | Not calculated |
| Tinospora cordifolia Source : Tige(s) Extraction ratio : 9.09:1 Dry plant equivalent : 72.72 mg | 8.0 mg | Not calculated |
| Hemidesmus indicus Source : Racine Extraction ratio : 7.69:1 Dry plant equivalent : 18.46 mg | 2.4 mg | Not calculated |
| Acacia catechu Source : Bois Extraction ratio : 33.33:1 Dry plant equivalent : 333.30 mg | 10.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Stéarate de magnésium, Starch, Corn, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the relief of symptoms associated with dermatitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80037495
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.